Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus.

[1]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[2]  R. Faull,et al.  Trk receptor alterations in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[3]  E. Feldman,et al.  Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. , 1996, Cancer research.

[4]  M. Gallagher,et al.  Increased expression of type 1 insulin-like growth factor receptor messenger rna in rat hippocampal formation is associated with aging and behavioral impairment , 1996, Neuroscience.

[5]  Junying Yuan,et al.  Suppression of Interleukin-1-converting Enzyme-mediated Cell Death by Insulin-like Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[6]  C. Cotman,et al.  DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  P. Gluckman,et al.  Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. , 1996, The Journal of clinical investigation.

[8]  P. Schofield,et al.  Growth factors and apoptosis in development. The role of insulin like growth factor I and TGFbeta1 in regulating cell growth and cell death in a human teratocarcinoma derived cell line. , 1995, The International journal of developmental biology.

[9]  M. Harrigan,et al.  Beta amyloid is neurotoxic in hippocampal slice cultures , 1995, Neurobiology of Aging.

[10]  C. Arias,et al.  β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices , 1995, Journal of neuroscience research.

[11]  M. Dragunow,et al.  In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes , 1995, Neuroreport.

[12]  S. Younkin.  Evidence that Aβ42 is the real culprit in alzheimer's disease , 1995 .

[13]  Antonella,et al.  Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  R. Baserga,et al.  Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. , 1995, Cancer research.

[15]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[16]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.

[17]  J. Silver,et al.  Regional Differences in Reactive Gliosis Induced by Substrate-Bound β-Amyloid , 1994, Experimental Neurology.

[18]  P. Gluckman,et al.  Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. , 1994, Brain research. Molecular brain research.

[19]  N. Wilczak,et al.  Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease , 1994, Neuroscience Letters.

[20]  C. Behl,et al.  Amyloid β peptide induces necrosis rather than apoptosis , 1994, Brain Research.

[21]  C. Z. Zhu,et al.  Intraventricular Administration of Insulin and IGF-1 in Transient Forebrain Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  S. Arkins,et al.  Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. , 1993, Endocrinology.

[23]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[24]  L. Olson,et al.  The Biological Role of Truncated Insulin‐like Growth Factor‐1 and the Tripeptide GPE in the Central Nervous System a , 1993, Annals of the New York Academy of Sciences.

[25]  M. Dragunow,et al.  The Role of the Insulin‐like Growth Factor System in Neuronal Rescue a , 1993, Annals of the New York Academy of Sciences.

[26]  M. Gunning,et al.  The Effects of IGF-1 Treatment after Hypoxic-Ischemic Brain Injury in Adult Rats , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  J. Poirier,et al.  Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation , 1993, Neuroscience.

[28]  P. Gluckman,et al.  Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. , 1993, Brain research. Molecular brain research.

[29]  G. Forloni,et al.  Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.

[30]  C. White,et al.  The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system , 1993, Neurobiology of Aging.

[31]  I. Torres-Aleman,et al.  Expression of insulin-like growth factor I by astrocytes in response to injury , 1992, Brain Research.

[32]  A. Gunn,et al.  Expression of insulin-like growth factor-binding protein 2 (IGF-BP 2) following transient hypoxia-ischemia in the infant rat brain. , 1992, Brain research. Molecular brain research.

[33]  D. Borchelt,et al.  Toxicity of synthetic aβ peptides and modeling of alzheimer's disease , 1992, Neurobiology of Aging.

[34]  M. Raizada,et al.  Insulin‐Like Growth Factor I Receptor Binding in Brains of Alzheimer's and Alcoholic Patients , 1992, Journal of neurochemistry.

[35]  M. Mattson,et al.  IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  R. Frederickson.  Astroglia in Alzheimer's disease , 1992, Neurobiology of Aging.

[37]  H. Werner,et al.  Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: Comparison with insulin-like growth factors I and II , 1992, Neuroscience.

[38]  J. Clemens,et al.  Insulin-like growth factors in the response to cerebral ischemia , 1992, Molecular and Cellular Neuroscience.

[39]  P. Gluckman,et al.  A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. , 1992, Biochemical and biophysical research communications.

[40]  C. Cotman,et al.  β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease , 1992, Brain Research.

[41]  I. Torres-Aleman,et al.  Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain , 1991, Brain Research.

[42]  R. Quirion,et al.  Growth Factors and Lymphokines: Modulators of Cholinergic Neuronal Activity , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[43]  O. Hatase,et al.  Increase of extracellular insulin-like growth factor I (IGF-I) concentration following electrolytical lesion in rat hippocampus , 1991, Neuroscience Letters.

[44]  D. Mann.  Is the pattern of nerve cell loss in ageing and Alzheimer's disease a real, or only an apparent, selectivity? , 1991, Neurobiology of Aging.

[45]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[46]  C. Cotman,et al.  Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation , 1991, Experimental Neurology.

[47]  M. Kanje,et al.  Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve , 1989, Brain Research.

[48]  D. Dorsa,et al.  Insulin and insulin-like growth factors in the CNS , 1988, Trends in Neurosciences.

[49]  R. Crystal,et al.  Alveolar macrophages release an insulin-like growth factor I-type molecule. , 1988, The Journal of clinical investigation.

[50]  S. Gauthier,et al.  Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's Disease , 1988, Journal of neurochemistry.

[51]  S. Burgess,et al.  Characterization of a neuronal subtype of insulin-like growth factor I receptor. , 1987, The Journal of biological chemistry.

[52]  S. Gammeltoft,et al.  Two types of receptor for insulin‐like growth factors in mammalian brain. , 1985, The EMBO journal.

[53]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[54]  M. Viitanen,et al.  Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[55]  J. Tinklenberg,et al.  Chapter 40: Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease , 1992 .

[56]  C. Nemeroff,et al.  Neurotransmitters and neuropeptides in Alzheimer's disease. , 1991, The Psychiatric clinics of North America.

[57]  V. Sara,et al.  Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. , 1991, Development.